For Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition
By Linda E. Mccuistion Phd
Questions And Answers Graded A+
,Table Of Contents
Chapter 01: Drug Development And Ethical Considerations .............................................................. 4
Chapter 02: Pharmacokinetics, Pharmacodynamics, Andpharmacogenetics ................................. 11
Chapter 03: Cultural Considerations .............................................................................................. 18
Chapter 04: Complementary And Alternative Therapies .................................................................. 21
Chapter 05: Pediatric Considerations............................................................................................. 26
Chapter 06: Geriatric Considerations ............................................................................................. 31
Chapter 07: Drugs In Substance Use Disorder ................................................................................ 36
Chapter 08: The Nursing Process And Patient-Centered Care .......................................................... 45
Chapter 09: Safety And Quality ...................................................................................................... 49
Chapter 10: Drug Administration .................................................................................................... 54
Chapter 11: Drug Calculations ....................................................................................................... 58
Chapter 12: Fluid Volume And Electrolytes ..................................................................................... 63
Chapter 13: Vitamin And Mineral Replacement ............................................................................... 70
Chapter 14: Nutritional Support ..................................................................................................... 76
Chapter 15: Adrenergic Agonists And Antagonists ......................................................................... 83
Chapter 16: Cholinergic Agonists And Antagonists ......................................................................... 89
Chapter 17: Stimulants .................................................................................................................. 94
Chapter 18: Depressants .............................................................................................................. 98
Chapter 19: Antiseizure Drugs ..................................................................................................... 103
Chapter 20: Drugs For Parkinsonism And Alzheimer's Disease ..................................................... 109
Chapter 21: Drugs For Neuromuscular Disorders And Musclespasms ........................................... 114
Chapter 22: Antipsychotics And Anxiolytics ................................................................................. 120
,Chapter 23: Antidepressants And Mood Stabilizers ..................................................................... 126
Chapter 24: Antiinflammatories ................................................................................................... 132
Chapter 25: Analgesics ............................................................................................................... 144
Chapter 26: Antibacterials ........................................................................................................... 150
Chapter 27: Antituberculars, Antifungals, And Antivirals ............................................................... 159
Chapter 28: Peptides, Antimalarials, And Anthelmintics ............................................................... 165
Chapter 29: Hiv- And Aids-Related Drugs ...................................................................................... 175
Chapter 30: Transplant Drugs ...................................................................................................... 179
Chapter 31: Vaccines .................................................................................................................. 182
Chapter 32: Anticancer Drugs ..................................................................................................... 186
Chapter 33: Targeted Therapies To Treat Cancer ............................................................................ 190
Chapter 34: Biologic Response Modifiers ..................................................................................... 192
Chapter 35: Upper Respiratory Disorders ..................................................................................... 196
Chapter 36: Lower Respiratory Disorders ...................................................................................... 200
Chapter 37: Cardiac Glycosides, Antianginals, Andantidysrhythmics ............................................ 204
Chapter 38: Diuretics .................................................................................................................. 211
Chapter 39: Antihypertensives .................................................................................................... 214
Chapter 40: Anticoagulants, Antiplatelets, And Thrombolytics ....................................................... 220
Chapter 41: Antihyperlipidemics And Peripheral Vasodilators ...................................................... 225
Chapter 42: Gastrointestinal Tract Disorders ................................................................................ 229
Chapter 43: Antiulcer Drugs ........................................................................................................ 240
Chapter 44: Eye And Ear Disorders .............................................................................................. 245
Chapter 45: Dermatologic Disorders ............................................................................................ 248
Chapter 46: Pituitary, Thyroid, Parathyroid, And Adrenaldisorders ................................................ 252
Chapter 47: Antidiabetics ............................................................................................................ 258
Chapter 48: Urinary Disorders ..................................................................................................... 264
Chapter 49: Pregnancy And Preterm Labor .................................................................................. 268
Chapter 50: Labor, Delivery, And Postpartum ............................................................................... 273
Chapter 51: Neonatal And Newborn ............................................................................................. 276
, Chapter 52: Women's Reproductive Health ................................................................................... 280
Chapter 53: Men's Reproductive Health ....................................................................................... 283
Chapter 54: Sexually Transmitted Infections ................................................................................ 286
Chapter 55: Adult And Pediatric Emergency Drugs....................................................................... 290
Chapter 01: Drug Development And Ethical Considerations
Multiple Choice